Multifunctional Theranostic Nanoparticles for Enhanced Tumor Targeted Imaging and Synergistic FUS/Chemotherapy on Murine 4T1 Breast Cancer Cell

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:10.3322/caac.21590
   PubMed Web of Science ®Google Scholar
• Waks AG, Winer EP. Breast cancer treatment: a review. JAMA. 2019;321(3):288–300. doi:10.1001/jama.2018.19323
   PubMed Web of Science ®Google Scholar
• Bianchini G, Balko JM, Mayer IA, Sanders ME, Gianni L. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol. 2016;13(11):674–690. doi:10.1038/nrclinonc.2016.66
   PubMed Web of Science ®Google Scholar
• Duc NM, Keserci B. Emerging clinical applications of high-intensity focused ultrasound. Diagn Interv Radiol. 2019;25(5):398–409. doi:10.5152/dir.2019.18556
   PubMed Web of Science ®Google Scholar
• Ning Z, Xie J, Chen Q, et al. HIFU is safe, effective, and feasible in pancreatic cancer patients: a monocentric retrospective study among 523 patients. Onco Targets Ther. 2019;12:1021–1029. doi:10.2147/OTT.S185424
   PubMed Web of Science ®Google Scholar
• Orgera G, Monfardini L, Della Vigna P, et al. High-intensity focused ultrasound (HIFU) in patients with solid malignancies: evaluation of feasibility, local tumour response and clinical results. Radiol Med. 2011;116(5):734–748. doi:10.1007/s11547-011-0634-4
   PubMed Web of Science ®Google Scholar
• You Y, Wang Z, Ran H, et al. Nanoparticle-enhanced synergistic HIFU ablation and transarterial chemoembolization for efficient cancer therapy. Nanoscale. 2016;8(7):4324–4339. doi:10.1039/C5NR08292G
   PubMed Web of Science ®Google Scholar
• Ektate K, Munteanu MC, Ashar H, Malayer J, Ranjan A. Chemoimmunotherapy of colon cancer with focused ultrasound and Salmonella-laden temperature sensitive liposomes (thermobots). Sci Rep. 2018;8:13062.
   PubMed Web of Science ®Google Scholar
• Wilson K, Homan K, Emelianov S. Biomedical photoacoustics beyond thermal expansion using triggered nanodroplet vaporization for contrast-enhanced imaging. Nat Commun. 2012;3(1):618. doi:10.1038/ncomms1627
   PubMed Web of Science ®Google Scholar
• Li DS, Kripfgans OD, Fabiilli ML, Brian Fowlkes J, Bull JL. Initial nucleation site formation due to acoustic droplet vaporization. Appl Phys Lett. 2014;104(6):063703. doi:10.1063/1.4864110
   PubMed Web of Science ®Google Scholar
• Hu CM, Zhang L. Nanoparticle-based combination therapy toward overcoming drug resistance in cancer. Biochem Pharmacol. 2012;83(8):1104–1111. doi:10.1016/j.bcp.2012.01.008
   PubMed Web of Science ®Google Scholar
• Tacar O, Sriamornsak P, Dass CR. Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol. 2013;65(2):157–170. doi:10.1111/j.2042-7158.2012.01567.x
   PubMed Web of Science ®Google Scholar
• Maeda M, Muragaki Y, Okamoto J, et al. Sonodynamic therapy based on combined use of low dose administration of epirubicin-incorporating drug delivery system and focused ultrasound. Ultrasound Med Biol. 2017;43(10):2295–2301. doi:10.1016/j.ultrasmedbio.2017.06.003
   PubMed Web of Science ®Google Scholar
• Zhu ZF, Chen LJ, Lu R, et al. Tripeptide tyroserleutide plus doxorubicin: therapeutic synergy and side effect attenuation. BMC Cancer. 2008;8(1):342. doi:10.1186/1471-2407-8-342
   PubMed Web of Science ®Google Scholar
• Pawar A, Prabhu P. Nanosoldiers: a promising strategy to combat triple negative breast cancer. Biomed Pharmacother. 2019;110:319–341. doi:10.1016/j.biopha.2018.11.122
   PubMed Web of Science ®Google Scholar
• Cabeza L, Ortiz R, Arias JL, et al. Enhanced anti-tumor activity of doxorubicin in breast cancer through the use of poly(butylcyanoacrylate) nanoparticles. Int J Nanomed. 2015;10:1291–1306.
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhong Y, Liu W, et al. Enhanced chemotherapeutic efficacy of the low-dose doxorubicin in breast cancer via nanoparticle delivery system crosslinked hyaluronic acid. Drug Deliv. 2019;26(1):12–22. doi:10.1080/10717544.2018.1507057
   PubMed Web of Science ®Google Scholar
• Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Preat V. PLGAbased nanoparticles: an overview of biomedical applications. J Controlled Release. 2012;161(2):505–522. doi:10.1016/j.jconrel.2012.01.043
   PubMed Web of Science ®Google Scholar
• Barbas AS, Mi J, Clary BM, White RR. Aptamer applications for targeted cancer therapy. Future Oncol. 2010;6(7):1117e26. doi:10.2217/fon.10.67
   Web of Science ®Google Scholar
• Soundararajan S, Chen W, Spicer EK, Courtenay-Luck N, Fernandes DJ. The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells. Cancer Res. 2008;68(7):2358–2365. doi:10.1158/0008-5472.CAN-07-5723
   PubMed Web of Science ®Google Scholar
• Soundararajan S, Wang L, Sridharan V, et al. Plasma membrane nucleolin is a receptor for the anticancer aptamer AS1411 in MV4-11 leukemia cells. Mol Pharmacol. 2009;76(5):984–991. doi:10.1124/mol.109.055947
   PubMed Web of Science ®Google Scholar
• Kong N, Deng M, Sun XN, Chen YD, Sui XB. Polydopamine-functionalized CA-(PCL-ran-PLA) nanoparticles for target delivery of docetaxel and chemo-photothermal therapy of breast cancer. Front Pharmacol. 2018;9:125. doi:10.3389/fphar.2018.00125
   PubMed Web of Science ®Google Scholar
• Mousnier L, Huang N, Morvan E, Fattal E, Tsapis N. Influence of polymer end- chemistry on the morphology of perfluorohexane polymeric microcapsules intended as ultrasound contrast agents. Int J Pharm. 2014;471(1–2):10–17. doi:10.1016/j.ijpharm.2014.05.012
   PubMed Web of Science ®Google Scholar
• Su YL, Fang JH, Liao CY, Lin CT, Li YT, Hu SH. Targeted mesoporous iron oxide nanoparticles-encapsulated perfluorohexane and a hydrophobic drug for deep tumor penetration and therapy. Theranostics. 2015;5(11):1233–1248. doi:10.7150/thno.12843
   PubMed Web of Science ®Google Scholar
• Björnmalm M, Thurecht KJ, Michael M, Scott AM, Caruso F. Bridging bio-nano science and cancer nanomedicine. ACS Nano. 2017;11(10):9594–9613. doi:10.1021/acsnano.7b04855
   PubMed Web of Science ®Google Scholar
• Shi Y, van der Meel R, Chen X, Lammers T. The EPR effect and beyond: strategies to improve tumor targeting and cancer nanomedicine treatment efficacy. Theranostics. 2020;10(17):7921–7924. doi:10.7150/thno.49577
   PubMed Web of Science ®Google Scholar
• Davies MN, Sansom CE, Beazley C, Moss DS. A novel predictive technique for the MHC class II peptide-binding interaction. Mol Med. 2003;9(9–12):220–225. doi:10.2119/2003-00032.Sansom
   PubMed Web of Science ®Google Scholar
• Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer. 2004;4(11):891–899. doi:10.1038/nrc1478
   PubMed Web of Science ®Google Scholar
• Unsoy G, Khodadust R, Yalcin S, Mutlu P, Gunduz U. Synthesis of doxorubicin loaded magnetic chitosan nanoparticles for ph responsive targeted drug delivery. Eur J Pharm Sci. 2014;62:243–250. doi:10.1016/j.ejps.2014.05.021
   PubMed Web of Science ®Google Scholar
• Li G, Li J, Hou Y, et al. Levofloxacin-loaded nanosonosensitizer as a highly efficient therapy for bacillus Calmette-Guerin infections based on bacteria-specific labeling and sonotheranostic strategy. Int J Nanomedicine. 2021;16:6553–6573. doi:10.2147/IJN.S321631
   PubMed Web of Science ®Google Scholar
• Bowerman CJ, Byrne JD, Chu KS, et al. Docetaxel-loaded PLGA nanoparticles improve efficacy in taxane-resistant triple-negative breast cancer. Nano Lett. 2017;17(1):242–248. doi:10.1021/acs.nanolett.6b03971
   PubMed Web of Science ®Google Scholar
• Girvan AC, Teng Y, Casson LK, et al. AGRO100 inhibits activation of nuclear factor-kappaB (NF-kappaB) by forming a complex with NF-kappaB essential modulator (NEMO) and nucleolin. Mol Cancer Ther. 2006;5(7):1790–1799. doi:10.1158/1535-7163.MCT-05-0361
   PubMed Web of Science ®Google Scholar
• Geremia I, Pavlenko D, Maksymow K, Rüth M, Lemke HD, Stamatialis D. Ex vivo evaluation of the blood compatibility of mixed matrix haemodialysis membranes. Acta Biomater. 2020;111:118–128. doi:10.1016/j.actbio.2020.05.016
   PubMed Web of Science ®Google Scholar
• Thanh VM, Nguyen TH, Tran TV, et al. Low systemic toxicity nanocarriers fabricated from heparin-mPEG and PAMAM dendrimers for controlled drug release. Mater Sci Eng C Mater Biol Appl. 2018;82:291–298. doi:10.1016/j.msec.2017.07.051
   PubMed Web of Science ®Google Scholar
• Ugrinova I, Petrova M, Chalabi-Dchar M, Bouvet P. Multifaceted nucleolin protein and its molecular partners in oncogenesis. Adv Protein Chem Struct Biol. 2018;111:133–164.
   PubMed Web of Science ®Google Scholar
• Chen Z, Xu X. Roles of nucleolin: focus on cancer and anti-cancer therapy. Saudi Med J. 2016;37(12):1312–1318. doi:10.15537/smj.2016.12.15972
   PubMed Web of Science ®Google Scholar
• Varty K, O’Brien C, Ignaszak A. Breast cancer aptamers: current sensing targets, available aptamers, and their evaluation for clinical use in diagnostics. Cancers. 2021;13(16):3984. doi:10.3390/cancers13163984
   PubMed Web of Science ®Google Scholar
• Yang Y, Jing L, Li X, Lin L, Yue X, Dai Z. Hyaluronic acid conjugated magnetic Prussian Blue@Quantum Dot nanoparticles for cancer theranostics. Theranostics. 2017;7(2):466–481. doi:10.7150/thno.17411
   PubMed Web of Science ®Google Scholar
• Tang H, Guo Y, Peng L, et al. In vivo targeted, responsive, and synergistic cancer nanotheranostics by magnetic resonance imaging-guided synergistic high-intensity focused ultrasound ablation and chemotherapy. ACS Appl Mater Interfaces. 2018;10(18):15428–15441. doi:10.1021/acsami.8b01967
   PubMed Web of Science ®Google Scholar
• Cao Y, Chen Y, Yu T, et al. Drug release from phase-changeable nanodroplets triggered by low-intensity focused ultrasound. Theranostics. 2018;8(5):1327–1339. doi:10.7150/thno.21492
   PubMed Web of Science ®Google Scholar
• Yildirim A, Shi D, Roy S, et al. Nanoparticle-mediated acoustic cavitation enables high intensity focused ultrasound ablation without tissue heating. ACS Appl Mater Interfaces. 2018;10(43):36786–36795. doi:10.1021/acsami.8b15368
   PubMed Web of Science ®Google Scholar
• Chen Y, Chen H, Shi J. Nanobiotechnology promotes noninvasive high-intensity focused ultrasound cancer surgery. Adv Healthc Mater. 2015;4(1):158–165. doi:10.1002/adhm.201400127
   PubMed Web of Science ®Google Scholar
• Goodwin AP, Nakatsuka MA, Mattrey RF. Stimulus-responsive ultrasound contrast agents for clinical imaging: motivations, demonstrations, and future directions. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2015;7(1):111–123. doi:10.1002/wnan.1285
   PubMed Web of Science ®Google Scholar
• Dogan BE, Turnbull LW. Imaging of triple-negative breast cancer. Ann Oncol. 2012;23 Suppl 6:vi23–vi29. doi:10.1093/annonc/mds191
   PubMed Web of Science ®Google Scholar
• Rosenthal I, Sostaric JZ, Riesz P. Sonodynamic therapy – a review of the synergistic effects of drugs and ultrasound. Ultrason Sonochem. 2004;11(6):349–363. doi:10.1016/j.ultsonch.2004.03.004
   PubMed Web of Science ®Google Scholar
• Matafonova G, Batoev V. Review on low- and high-frequency sonolytic, sonophotolytic and sonophotochemical processes for inactivating pathogenic microorganisms in aqueous media. Water Res. 2019;166:115085. doi:10.1016/j.watres.2019.115085
   PubMed Web of Science ®Google Scholar
• Srinivas US, Tan BWQ, Vellayappan BA, Jeyasekharan AD. ROS and the DNA damage response in cancer. Redox Biol. 2019;25:101084. doi:10.1016/j.redox.2018.101084
   PubMed Web of Science ®Google Scholar
• Sosa V, Moliné T, Somoza R, Paciucci R, Kondoh H, LLeonart ME. Oxidative stress and cancer: an overview. Ageing Res Rev. 2013;12(1):376–390. doi:10.1016/j.arr.2012.10.004
   PubMed Web of Science ®Google Scholar
• Pastushenko I, Blanpain C. EMT transition states during tumor progression and metastasis. Trends Cell Biol. 2019;29(3):212–226. doi:10.1016/j.tcb.2018.12.001
   PubMed Web of Science ®Google Scholar
• Musaelyan A, Lapin S, Nazarov V, et al. Vimentin as antigenic target in autoimmunity: a comprehensive review. Autoimmun Rev. 2018;17(9):926–934. doi:10.1016/j.autrev.2018.04.004
   PubMed Web of Science ®Google Scholar
• Satelli A, Li S. Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci. 2011;68(18):3033–3046. doi:10.1007/s00018-011-0735-1
   PubMed Web of Science ®Google Scholar
• Gong C, Yang B, Shi Y, et al. Factors influencing the ablative efficiency of high intensity focused ultrasound (HIFU) treatment for adenomyosis: a retrospective study. Int J Hyperthermia. 2016;32(5):496–503. doi:10.3109/02656736.2016.1149232
   PubMed Web of Science ®Google Scholar
• Chitnis PV, Farny CH, Roy RA. SVD-based separation of stable and inertial cavitation signals applied to passive cavitation mapping during HIFU. IEEE Trans Ultrason Ferroelectr Freq Control. 2019;66(5):857–866. doi:10.1109/TUFFC.2019.2898917
   PubMed Web of Science ®Google Scholar
• Xu S, Chang N, Wang R, et al. Acoustic droplet vaporization and inertial cavitation thresholds and efficiencies of nanodroplets emulsions inside the focused region using a dual-frequency ring focused ultrasound. Ultrason Sonochem. 2018;48:532–537. doi:10.1016/j.ultsonch.2018.07.020
   PubMed Web of Science ®Google Scholar
• Holt RG, Roy RA. Measurements of bubble-enhanced heating from focused, MHz-frequency ultrasound in a tissue-mimicking material. Ultrasound Med Biol. 2001;27(10):1399–1412. doi:10.1016/S0301-5629(01)00438-0
   PubMed Web of Science ®Google Scholar
• Farny CH, Glynn Holt R, Roy RA. The correlation between bubble-enhanced HIFU heating and cavitation power. IEEE Trans Biomed Eng. 2010;57(1):175–184. doi:10.1109/TBME.2009.2028133
   PubMed Web of Science ®Google Scholar
• Coussios CC, Farny CH, Haar GT, Roy RA. Role of acoustic cavitation in the delivery and monitoring of cancer treatment by high-intensity focused ultrasound (HIFU) [published correction appears in Int J Hyperthermia. 2007 May;23(3):327]. Int J Hyperthermia. 2007;23(2):105–120. doi:10.1080/02656730701194131
   PubMed Web of Science ®Google Scholar
• Tang J, Guha C, Tomé WA. Biological effects induced by non-thermal ultrasound and implications for cancer therapy: a review of the current literature. Technol Cancer Res Treat. 2015;14(2):221–235. doi:10.7785/tcrt.2012.500407
   PubMed Web of Science ®Google Scholar
• Dittmar KM, Xie J, Hunter F, et al. Pulsed high-intensity focused ultrasound enhances systemic administration of naked DNA in squamous cell carcinoma model: initial experience. Radiology. 2005;235(2):541–546. doi:10.1148/radiol.2352040254
   PubMed Web of Science ®Google Scholar
• Riesz P, Kondo T. Free radical formation induced by ultrasound and its biological implications. Free Radic Biol Med. 1992;13(3):247–270. doi:10.1016/0891-5849(92)90021-8
   PubMed Web of Science ®Google Scholar
• Honda H, Kondo T, Zhao QL, Feril LB Jr, Kitagawa H. Role of intracellular calcium ions and reactive oxygen species in apoptosis induced by ultrasound. Ultrasound Med Biol. 2004;30(5):683–692. doi:10.1016/j.ultrasmedbio.2004.02.008
   PubMed Web of Science ®Google Scholar
• Wang P, Wang X, Liu Q, Zhao X, Cao B, Zhao P. Comparison between sonodynamic effects with protoporphyrin IX and hematoporphyrin on the cytoskeleton of Ehrlich ascites carcinoma cells. Cancer Biother Radiopharm. 2010;25(1):55–64. doi:10.1089/cbr.2008.0604
   PubMed Web of Science ®Google Scholar
• Hu Z, Yang XY, Liu Y, et al. Investigation of HIFU-induced anti-tumor immunity in a mice tumor model. J Transl Med. 2007;5(1):34. doi:10.1186/1479-5876-5-34
   PubMed Web of Science ®Google Scholar
• Lu P, Zhu XQ, Xu ZL, Zhou Q, Zhang J, Wu F. Increased infiltration of activated tumor-infiltrating lymphocytes after high intensity focused ultrasound ablation of human breast cancer. Surgery. 2009;145(3):286–293. doi:10.1016/j.surg.2008.10.010
   PubMed Web of Science ®Google Scholar
• van den Bijgaart RJ, Eikelenboom DC, Hoogenboom M, Fütterer JJ, den Brok MH, Adema GJ. Thermal and mechanical high-intensity focused ultrasound: perspectives on tumor ablation, immune effects and combination strategies. Cancer Immunol Immunother. 2017;66(2):247–258. doi:10.1007/s00262-016-1891-9
   PubMed Web of Science ®Google Scholar
• Ji R, Karakatsani ME, Burgess M, Smith M, Murillo MF, Konofagou EE. Cavitation-modulated inflammatory response following focused ultrasound blood-brain barrier opening. J Control Release. 2021;337:458–471. doi:10.1016/j.jconrel.2021.07.042
   PubMed Web of Science ®Google Scholar
• Chen KT, Wei KC, Liu HL. Focused ultrasound combined with microbubbles in central nervous system applications. Pharmaceutics. 2021;13(7):1084. doi:10.3390/pharmaceutics13071084
   PubMed Web of Science ®Google Scholar
• Tang H, Zheng Y, Chen Y. Materials chemistry of nanoultrasonic biomedicine. Adv Mater. 2017;29(10):1604105. doi:10.1002/adma.201604105
   Web of Science ®Google Scholar
• Chen Y, Ye D, Wu M, et al. Break-up of two-dimensional MnO2 nanosheets promotes ultrasensitive pH-triggered theranostics of cancer. Adv Mater. 2014;26(41):7019–7026. doi:10.1002/adma.201402572
   PubMed Web of Science ®Google Scholar
• Li J, Arnal B, Wei CW, et al. Magneto-optical nanoparticles for cyclic magnetomotive photoacoustic imaging. ACS Nano. 2015;9(2):1964–1976. doi:10.1021/nn5069258
   PubMed Web of Science ®Google Scholar
• Nomikou N, McHale AP. Exploiting ultrasound-mediated effects in delivering targeted, site-specific cancer therapy. Cancer Lett. 2010;296(2):133–143. doi:10.1016/j.canlet.2010.06.002
   PubMed Web of Science ®Google Scholar
• Sheybani ND, Price RJ. Perspectives on recent progress in focused ultrasound immunotherapy. Theranostics. 2019;9(25):7749–7758. doi:10.7150/thno.37131
   PubMed Web of Science ®Google Scholar